Showing results (81-90 of 119) with videos related to
Sort By:
Pageof 12
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 4, 2019
Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rateKen Lee Chin, Timothy Collier, Stuart Pocock, et al.American Journal of Human Genetics|November 14, 2007
Contribution of SHANK3 mutations to autism spectrum disorderRainald Moessner, Christian R Marshall, James S Sutcliffe, et al.European Heart Journal|July 19, 2013
The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trialTimothy J Collier, Stuart J Pocock, John J V McMurray, et al.Plos One|November 15, 2021
Neuroinflammation, body temperature and behavioural changes in CD1 male mice undergoing acute restraint stress: An exploratory studyVeronica Redaelli, Alice Bosi, Fabio Luzi, et al.Circulation. Heart Failure|June 15, 2021
Impact of Insulin Treatment on the Effect of Eplerenone: Insights From the EMPHASIS-HF TrialJoão Pedro Ferreira, Zohra Lamiral, John J V McMurray, et al.Circulation|October 9, 2012
Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizationsJennifer K Rogers, John J V McMurray, Stuart J Pocock, et al.Digestive Surgery|August 29, 2015
Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CTVinod Malik, Mark Harmon, Ciaran Johnston, et al.American Journal of Preventive Cardiology|May 23, 2024
Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trialsFrederick Berro Rivera, Linnaeus Louisse A Cruz, John Vincent Magalong, et al.Journal of the American College of Cardiology|July 2, 2013
Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)Romain Eschalier, John J V McMurray, Karl Swedberg, et al.American Journal of Preventive Cardiology|March 29, 2024
Atherosclerotic coronary plaque regression from lipid-lowering therapies: A meta-analysis and meta-regressionFrederick Berro Rivera, Sung Whoy Cha, Michelle Capahi Varona, et al.Pageof 12